Arip MT of the tab. of 10 mg No. 30

tablets Arip MT are applied for:

• Treatment of bad attacks of schizophrenia and for maintenance therapy at patients with schizophrenia.
• Treatment of sharp maniacal episodes of bipolar disorder of the I type and for maintenance therapy at patients with bipolar disorder of the I type who before it transferred the maniacal or mixed episode.

Structure

Active ingredient: aripiprazole;

aripiprazol (in the form of granulate of an aripiprazol) - 10 mg;

Excipients: mannitol (E 421), ferrous oxide yellow (E172), silicon dioxide colloidal, magnesium stearate, aspartame (E 951), fragrance pineapple, mango fragrance, krospovidon, talc, citric acid monohydrate.

Contraindication

Hypersensitivity to an aripiprazol or to any other component which is a part of drug. Children's age.

to use Drug inside.

in case of simultaneous introduction of the powerful inductors CYP3A4 from an aripiprazol a dose of an aripiprazol should be raised. If the inductor CYP3A4 a dose of an aripiprazol is excluded from the scheme of the combined treatment it is necessary to reduce to recommended

Feature of use

Pregnant

In connection with insufficient information about safety of use of an aripiprazol during pregnancy can only appoint medicament when the expected advantage for the pregnant woman exceeds potential risk for a fruit.

Children

On it is applied by children.

Drivers

It is contraindicated.

symptoms, Potentially important from the medical point of view, which were observed the lethargy, the increased arterial blood pressure, drowsiness, tachycardia, nausea, vomiting and diarrhea were p>

.

Side effects

Most frequent side reactions were an akathisia and nausea.

Interaction

Owing to antagonism to α1-адренорецепторов aripiprazol can enhance effect of some antihypertensive drugs.

As aripiprazol influences the central nervous system (CNS), it is necessary to be careful in case of the concomitant use of alcohol or medicaments influencing central nervous system in connection with possible cross undesirable reactions, for example a sedation.

Should be applied with care aripiprazol in combination with other medicines which extend an interval of QT or break electrolytic balance.

to Store

in original packing at a temperature not above 25 °C.

to Store

out of children's reach.

Expiration date - 3 years.